MTOR and pancreatic neoplasm: As HSP90 expression is regulated by PI3K/AKT/mTOR axis [8], we next evaluated whether the activation of mTOR complexes (mTORC1 and mTORC2) could correlate with expression of HSP90 in Apigenin-treated pancreatic cancer cells.